Xcout Intel
Animol Discovery, Inc.
Animol Discovery, Inc. is a private biotechnology and drug discovery company founded in 2019. Headquartered in Boston, Massachusetts, the firm focuses on advancing pharmaceutical research and therapeutic development. It operates within the life sciences sector.
Subscribe to see Animol Discovery, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Animol Discovery, Inc. at a glance
Animol Discovery, Inc. is an animal health company headquartered in United States. Its most recent funding round raised $4M in November 2024. Xcout tracks 12 named people at Animol Discovery, Inc., including Philip Austin (Chief Executive Officer).
Animol Discovery, Inc. leadership
- Philip AustinChief Executive Officer
- Marijn E. DekkersChairman, Novalis LifeSciences
- Douglas E. HutchensCSO
- Andrew CalabreseScientific Co-Founder
- Logan AndrewsHead of Program Management
- Philip AustinExecutive Officer
6 more named people on record for Animol Discovery, Inc., with roles, board committees and tenure — see the full roster →
Animol Discovery, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $4M | — | |
| SEC Form D filing | $32M | — | |
| Series B | $34M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Animol Discovery, Inc. competitors
A few of Animol Discovery, Inc.'s closest competitors — see the full list of competitors and alternatives →
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Ambagon Therapeutics, Inc. is a biotechnology holding company founded in 2020 and located in San Francisco, California, focusing on drug discovery pipelines.
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
AI Proteins, Inc. is a growing biotechnology company based in Boston, Massachusetts, that aims to transform the development of oral biologic therapies for major diseases.
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools, and automation to discover novel small molecules.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Get Animol Discovery, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Animol Discovery, Inc. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access